Suppr超能文献

滤泡性淋巴瘤中染色体异常的预后价值

Prognostic value of chromosomal abnormalities in follicular lymphoma.

作者信息

Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A, Monconduit M, Bastard C

机构信息

Department of Clinical Hematology, Centre Henri Becquerel, Rouen, France.

出版信息

Blood. 1994 Aug 15;84(4):1043-9.

PMID:8049424
Abstract

The t(14;18)(q32;q21) chromosomal translocation is observed in more than 75% of cases of follicular lymphoma. Several additional chromosomal abnormalities, which might contribute to tumor progression, have also been described. However, prognostic implications of cytogenetic features in follicular lymphoma have not been clearly established. In an attempt to correlate cytogenetic findings with clinical outcome, we have studied survival and risk of transformation into a more aggressive lymphoma in 66 follicular lymphoma patients from whom a lymph node had been karyotyped at the time of diagnosis. A t(14;18) was the most common abnormality, having been observed in 51 patients (77%), but this showed no correlation with clinical outcome. Seventeen other recurrent numerical or structural abnormalities were identified in more than 10% of the patients. A high percentage of cells (> or = 90%) with abnormal metaphases and a number of chromosomal breaks higher than 6 were associated with a poor survival (P > .01 each). Patients with an abnormality of chromosome region 1p21-22 (P < .01), of 6q23-26 (P < .001), or of the short arm of chromosome 17 (P < .001) had a significantly shorter survival in univariate analysis. Multivariate analysis identified a break at 6q23-26 (P = .01) and 17p (P = .01) as independent prognostic factors in this population. The risk of transformation into a diffuse large-cell lymphoma was significantly higher in patients with either a 6q23-26 (P < .001) or a 17p (P < .01) abnormality. Chromosomal analysis of follicular lymphoma at the time of diagnosis can thus provide important information about the risk of transformation and survival.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在超过75%的滤泡性淋巴瘤病例中可观察到t(14;18)(q32;q21)染色体易位。还描述了其他几种可能促进肿瘤进展的染色体异常。然而,滤泡性淋巴瘤细胞遗传学特征的预后意义尚未明确确立。为了将细胞遗传学结果与临床结局相关联,我们研究了66例滤泡性淋巴瘤患者的生存情况以及转化为侵袭性更强的淋巴瘤的风险,这些患者在诊断时对其淋巴结进行了核型分析。t(14;18)是最常见的异常,在51例患者(77%)中观察到,但这与临床结局无相关性。在超过10%的患者中还发现了其他17种复发性数目或结构异常。中期相异常的细胞比例高(≥90%)以及染色体断裂数超过6个与生存不良相关(每项P>.01)。在单因素分析中,染色体区域1p21 - 22异常(P<.01)、6q23 - 26异常(P<.001)或17号染色体短臂异常(P<.001)的患者生存时间显著缩短。多因素分析确定6q23 - 26断裂(P =.01)和17p断裂(P =.01)是该人群的独立预后因素。6q23 - 26异常(P<.001)或17p异常(P<.01)的患者转化为弥漫性大细胞淋巴瘤的风险显著更高。因此,诊断时对滤泡性淋巴瘤进行染色体分析可为转化风险和生存提供重要信息。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验